Zobrazeno 1 - 10
of 59
pro vyhledávání: '"A. E. Kuzminov"'
Autor:
Konstantin K. Laktionov, Elena V. Artamonova, Tatiana N. Borisova, Valeriy V. Breder, Iurii M. Bychkov, Liubov Iu. Vladimirova, Nikita M. Volkov, Stepan M. Ergnian, Albina S. Zhabina, Pavel V. Kononets, Alexander E. Kuzminov, Evgeny V. Levchenko, Olga A. Malikhova, Dimitr T. Marinov, Sergey V. Miller, Fedor V. Moiseenko, Valeriia V. Mochal’nikova, Sergei N. Novikov, Oleg V. Pikin, Elena V. Reutova, Evgenii O. Rodionov, Dina D. Sakaeva, Ksenia A. Sarantseva, Anna I. Semenova, Aleksei V. Smolin, Vladimir M. Sotnikov, Sergei A. Tuzikov, Igor N. Turkin, Igor E. Tyurin, Vladimir D. Chkhikvadze, Konstantin I. Kolbanov, Marina V. Chernykh, Andrei V. Chernichenko, Aleksandr A. Fedenko, Elena V. Filonenko, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian, Aleksei V. Butenko, Ilmira R. Gil’mutdinova, Irina V. Gridneva, Mikhail A. Eremushkin, Margarita A. Zernova, Boris S. Kasparov, Denis V. Kovlen, Kristina O. Kondrat’eva, Tatiana V. Konchugova, Svetlana B. Korotkova, Anton A. Krutov, Olga A. Obukhova, Gennadii N. Ponomarenko, Tatiana Iu. Semiglazova, Aleksandra M. Stepanova, Marina M. Khulamkhanova
Publikováno v:
Современная онкология, Vol 24, Iss 3, Pp 269-304 (2022)
Externí odkaz:
https://doaj.org/article/a2caace9aacc43548d9d996d4c2021f2
Autor:
A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 190-195 (2020)
Introduction. In modern recommendations for the treatment of localized small cell lung cancer (SCLC), preference is given to socalled «early» chemoradiotherapy (CRT), which has a number of limitations due to its pronounced toxicity. With regard to
Externí odkaz:
https://doaj.org/article/70b6de609e474687bfff73e5612c357a
Autor:
A. A. Markovich, A. A. Kuznetsova, V. A. Gorbunova, N. F. Orel, A. S. Odintsova, G. S. Emelyanova, A. E. Kuzminov
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 115-119 (2019)
The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib therapy in various dose regimens. Stable disease was achieved in 24 patients (72.7%), parti
Externí odkaz:
https://doaj.org/article/29b703d41c8746dbadeff556b5ccdea9
Publikováno v:
Современная онкология, Vol 20, Iss 3, Pp 5-9 (2018)
Introduction. Patients with advanced small cell lung cancer (SCLC) have an extremely poor prognosis on the background of standard chemotherapy combination of etoposide and platinum-based drugs. In a randomized, double-blind of СА184-156 phase III s
Externí odkaz:
https://doaj.org/article/70bacb626d7349df8314bc1704807dc4
Autor:
G. S. Emelianova, N. F. Orel, V. A. Gorbunova, A. A. Kolomeytseva, A. A. Kuznetsova, A. E. Kuzminov, A. A. Fedenko
Publikováno v:
Сибирский онкологический журнал, Vol 16, Iss 6, Pp 100-104 (2017)
Advanced well differentiated neuroendocrine tumors (NET) have poor sensitivity to chemotherapy. Biotherapy and targeted therapy are the main treatment options for these patients. Approaches to the 2nd and subsequent lines of treatment have not been d
Externí odkaz:
https://doaj.org/article/c0f77ee0f2584480bb4c96f6dbc1ffcb
Publikováno v:
Современная онкология, Vol 19, Iss 2, Pp 61-65 (2017)
It is still unknown whether the combination of IFN-α with octreotide has benefit compared with IFN-α alone. We compared efficacy and toxicyty of IFN-α and IFN-α plus octreotide in first line of therapy of patients with NETs. There was trend to lo
Externí odkaz:
https://doaj.org/article/48ae2c23b4b64722ba9e6208d0a0cb34
Autor:
G S Emelyanova, A E Kuzminov, N F Orel, A S Odintsova, A A Markovich, A A Kuznetsova, V A Gorbunova
Publikováno v:
Современная онкология, Vol 18, Iss 1, Pp 80-83 (2016)
Somatostatin analogs plays a key role in the treatment of disseminated well-differentiated functioning and nonfunctioning neuroendocrine tumors (NET). Its ingibit hormonal activity of NET by binding to somatostatin receptors, have antiproliferative e
Externí odkaz:
https://doaj.org/article/096f4df874c740de8cb54cfedc777cfe
Publikováno v:
Современная онкология, Vol 17, Iss 3, Pp 92-95 (2015)
Everolimus is the targeted drug approved for the treatment of neuroendocrine tumors (NET). Efficacy of everolimus in combination with octreotide-depo has been shown in Radiant-2 randomized trial in patients with well-differentiated NET in different l
Externí odkaz:
https://doaj.org/article/c9d46ea2b99742c4ba94b5121db4af31
Autor:
V. V. Breder, V. A. Gorbunova, N. F. Orel, K. V. Orlova, A. E. Kuzminov, T. A. Борисова, Yu. V. Bisovskaya, I. N. Gagarin, N. N. Mazurenko, V. V. Mochalnikova, E. N. Kholyavka
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 1, Pp 43-53 (2015)
The review literature regarding endovascular interventions for rectal cancer treatment is presented. The results of treatment of loco-regional rectal carcinoma by with the help of endovascular selective lipiodol oil chemoembolization of the rectal ar
Externí odkaz:
https://doaj.org/article/ea4e203c7f9b41479b951f16c44f0a49
Autor:
M. B Bychkov, A. E. Kuzminov
Publikováno v:
Russian Journal of Oncology. 25:127-135
The article present a review and experience from a a single institution on the morphology, diagnostics, and treatment (chemotherapy, radiation, targeted therapy, and immunotherapy)) of small cell lung cancer (SCLC). The characteristic molecular, gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a89faf429e822cbdacb2ef787455e6c6
https://doi.org/10.17816/1028-9984-2020-25-4-127-135
https://doi.org/10.17816/1028-9984-2020-25-4-127-135